This site is intended for US healthcare professionals

Video Library

VIDEO LIBRARY

CKD Progression in T2D video poster with play button
Luiza Caramori, MD, PhD, MSc, discusses the prevalence of CKD and T2D, as well as the driving factors behind CKD progression
Inflammation and Fibrosis Are Driven video poster with play button
Luiza Caramori, MD, PhD, MSc, explains the role of MR overactivation in inflammation and fibrosis
Inflammation and Fibrosis Leads to End video poster with play button

Luiza Caramori, MD, PhD, MSc, explores the kidney damage and CKD progression that can result from inflammation and fibrosis

Inflammation and Fibrosis in CKD video poster with play button
Rajiv Agarwal, MD, takes us through the impact that T2D has on MR signaling in the kidney
Understanding Cardiovascular Effects video poster with play button
Matthew A. Cavender, MD, MPH, FACC, speaks about how CKD increases the cardiovascular risk of patients with T2D
Drivers of CKD video poster with play button
Katherine R. Tuttle, MD, FACP, FASN, FNKF, examines 3 key drivers of CKD progression, particularly inflammation and fibrosis
Inflammation + Fibrosis Ultimately video poster with play button
Family physician Stephen Brunton tells us about the likelihood of end-stage renal disease in patients with CKD and T2D
Kidney Screening video poster with play button
Neil Skolnik, MD, chats about the guidelines-recommended tests to identify CKD in patients with T2D
Where's There's Smoke video poster with play button
Katherine R. Tuttle, MD, FACP, FASN, FNKF, takes a deep dive into CKD progression in T2D

How can you detect albuminuria in your patients with CKD and T2D?1

Find out here

CKD: chronic kidney disease; MR: mineralocorticoid receptor; T2D: type 2 diabetes.

Reference:

  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Int Suppl. 2013;3(1):1–150.